Loading...
Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale
Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...
Na minha lista:
| Udgivet i: | Contemp Clin Trials |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/ https://ncbi.nlm.nih.gov/pubmed/28254404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|